Publicaciones en colaboración con investigadores/as de Hospital de Cruces (305)

2024

  1. Advances and Challenges in Multidrug Resistant Tuberculosis (MDR-TB) Control

    Open Respiratory Archives

  2. Analysis of the Evolution of Tuberculosis in Men and Women in Spain Between 2017 and 2022. Is There a Different Incidence Decline by Gender?

    Archivos de Bronconeumologia, Vol. 60, Núm. 5, pp. 312-315

  3. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia

    Scientific reports, Vol. 14, Núm. 1, pp. 12726

  4. Bronchopulmonary colonization patterns in Spanish people with cystic fibrosis: Results of a national multicentre study

    Enfermedades Infecciosas y Microbiologia Clinica

  5. Cost-Sensitive Ordinal Classification Methods to Predict SARS-CoV-2 Pneumonia Severity

    IEEE Journal of Biomedical and Health Informatics, Vol. 28, Núm. 5, pp. 2613-2623

  6. Cost-effectiveness of a telemonitoring program (telEPOC program) in frequently admitted chronic obstructive pulmonary disease patients

    Journal of Telemedicine and Telecare, Vol. 30, Núm. 1, pp. 156-164

  7. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

    Microchemical Journal, Vol. 199

  8. Highlights 57th SEPAR Congress

    Open Respiratory Archives, Vol. 6, Núm. 4

  9. Impact of comorbidities on the achievement of specific therapeutic goals in biologic-treated asthma patients

    Allergy: European Journal of Allergy and Clinical Immunology

  10. Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease

    Archivos de Bronconeumologia, Vol. 60, Núm. 4, pp. 226-237

  11. Nontuberculous Mycobacteria Isolates in Respiratory Samples and Mycobacterial Pulmonary Disease in an Area of Northern Spain

    Open Respiratory Archives, Vol. 6, Núm. 4

  12. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  3. Change in physical activity related to admission for exacerbation in COPD patients

    Respiratory Medicine, Vol. 212

  4. Clinical and Treatment Outcome Differences Between the Most Common Nontuberculous Mycobacteria (NTM) in the Basque Country

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 765-767

  5. Correction to: Predictors of short‑term COPD readmission (Internal and Emergency Medicine, (2022), 17, 5, (1481-1490), 10.1007/s11739-022-02948-4)

    Internal and Emergency Medicine

  6. Dyspnoea after epileptic seizures: beyond aspiration pneumonia

    Internal and Emergency Medicine

  7. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  8. Factors associated with suboptimal response to monoclonal antibodies in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology